BridgeMD
New treatment option for Obesity
Official title Lifestyle Changes in Obese Males With Sexual Dysfunction and Tinnitus
ClinicalTrials.gov ID: NCT06716125
What this study is testing
- What it's testing
- obese male usually complain subjective tinnitus that may affect their sexual function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 45, men only
You may be able to join if
- obese person
- body mass index less than 40 kg/m2 and more than 30 kg/m2
- males with subjective tinnitus (bilateral presentation from at least 24 weeks).
- males with sexual dysfunction (erectile dysfunction from at least 24 weeks)
You likely can't join if
- cardiac diseased males
- respiratory diseased males
- hepatic, musculoskeletal, and hepatic diseased males
- diabetic males
The study team makes the final eligibility decision.
Where it's taking place
- Dokki, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 35 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dokki, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.